Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas

NCT03983551 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Proteinuria

Interventions

DRUG: Dipeptidyl Peptidase 4 Inhibitor
DRUG: Sulfonylurea

Sponsor

Changhua Christian Hospital